D. Von Hoff

2.0k citations
25 papers · 1.6k · 1 hit paper · h-index 11

Impact in

  • Oncology top 2%
    • Pancreatic and Hepatic Oncology Research
    • Cancer Treatment and Pharmacology
    • Colorectal Cancer Treatments and Studies
    • Cancer-related Molecular Pathways
    • Cancer Genomics and Diagnostics

Papers in

    • Cancer Treatment and Pharmacology 6
    • Pancreatic and Hepatic Oncology Research 3
    • HER2/EGFR in Cancer Research 2
    • Colorectal Cancer Treatments and Studies 2
    • Cancer therapeutics and mechanisms 4

D. Von Hoff

24 papers receiving 1.6k citations

D. Von Hoff's Hit Papers

Phase III Trial of Gemcitabine Plus Tipifarnib Compared With Gemcitabine Plus Placebo in Advanced Pancreatic Cancer 2004 · 647 citations
6470+7+14Years since publication200400600

Peers

D. Von Hoff
Comparison fields: 5 of 82
  • Oncology 1.0k
  • Cancer Research 308
  • Pulmonary and Respiratory Medicine 293
  • Molecular Biology 528
  • Genetics 65
Replace Lon Smith with:
Lon Smith United States
Suzanne Russo United States
Emily Dunn United States
Gregory Friberg United States
Nancy T. Sklarin United States
Felix Rückert Germany
Walter L. Vervenne Netherlands
Jeremy Kortmansky United States
Vanessa Deschoolmeester Belgium
Bunzo Nakata Japan
D. Von Hoff relative to Lon Smith United States Lon Smith's profile →
Citations per field
00.5×1.5×
Lon Smith · 1×
Citations per year

Countries citing papers authored by D. Von Hoff

Since Specialization
Citations

This map shows the geographic impact of D. Von Hoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Von Hoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Von Hoff more than expected).

Fields of papers citing papers by D. Von Hoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Von Hoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Von Hoff. The network helps show where D. Von Hoff may publish in the future.

Co-authors

The 25 scholars most cited alongside D. Von Hoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. Von Hoff Line = papers co-authored together D. Von Hoff links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase III Trial of Gemcitabine Plus Tipifarnib Compared With Gemcitabine Plus Placebo in Advanced Pancreatic Cancer
Hit paper breakdown →
2004647
2 2005260
3 1991163
4 1999149
5
DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic implications.
199588
6 201178
7
Effect of telomere and telomerase interactive agents on human tumor and normal cell lines.
200072
8 199743
9 200139
10 201438
11 199612
12
New anticancer agents in clinical development.
199510
13 20096
14
In vitro treatment of autologous bone marrow for neuroblastoma patients with anti GD2 monoclonal antibody and human complement: a pilot study.
19886
15 20094
16 20094
17
Doxorubicin and interferon: rationale and clinical experience.
19853
18 20062
19 19902
20 20042

About D. Von Hoff

D. Von Hoff is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Neurology, having authored 25 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), Cancer therapeutics and mechanisms (4 papers), Lung Cancer Treatments and Mutations (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), Cancer Genomics and Diagnostics (2 papers), Neuroblastoma Research and Treatments (2 papers), HER2/EGFR in Cancer Research (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (1.0k citations), Cancer Research (308 citations), Pulmonary and Respiratory Medicine (293 citations), Molecular Biology (528 citations) and Genetics (65 citations). D. Von Hoff has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Helmut Oettle, Petr Karásek, Juan José Pérez Ruixo, Eric Van Cutsem, Helgi van de Velde, Yves Humblet, Andrzej Szawłowski, Yue Ma, Howard Safran and H Neumann. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Investigational New Drugs and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact